Spontaneous bacterial peritonitis: Difference between revisions

From IDWiki
m (Text replacement - "== Presentation" to "== Clinical Manifestations")
mNo edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
== Definition ==
+
==Background==
   
* Primary infection of the ascitic fluid, diagnosed by ascites fluid with positive culture or with neutrophil count greater than 250
+
*Primary infection of the ascitic fluid, diagnosed by ascites fluid with positive culture or with neutrophil count greater than 250
   
  +
===Microbiology===
== Pathophysiology ==
 
   
 
*''[[Escherichia coli]]'' (43%)
* Intestinal bacterial overgrowth with increased intestinal permeability leads to translocation to intestinal lymph notes and bloodstream, which results in hematogenous seeding to ascitic fluid
 
 
*''[[Klebsiella pneumoniae]]'' (11%)
* Only occurs in portal hypertension, not in other causes of ascites
 
  +
*''[[Streptococcus pneumoniae]]'' (9%), particularly affecting people with [[HIV]] and prepubertal girls
 
*Other streptococcal species (19%)
 
*Enterobacteriaceae (4%)
 
*''[[Staphylococcus]]'' (3%)
 
*''[[Pseudomonas]]'' (1%)
 
*Miscellaneous (10%)
 
**''[[Aeromonas hydrophila]]'', in Korea
  +
**[[Peritoneal tuberculosis]]
  +
**[[Dimorphic fungi]]
   
 
===Pathophysiology===
== Bacteriology ==
 
   
 
*Intestinal bacterial overgrowth with increased intestinal permeability leads to translocation to intestinal lymph notes and bloodstream, which results in hematogenous seeding to ascitic fluid
* ''[[Escherichia coli]]'' (43%)
 
 
*Only occurs in portal hypertension, not in other causes of ascites
* ''[[Klebsiella pneumoniae]]'' (11%)
 
* ''[[Streptococcus pneumoniae]]'' (9%)
 
* Other streptococcal species (19%)
 
* Enterobacteriaceae (4%)
 
* ''[[Staphylococcus]]'' (3%)
 
* ''[[Pseudomonas]]'' (1%)
 
* Miscellaneous (10%)
 
** ''[[Aeromonas hydrophila]]'', in Korea
 
   
== Risk Factors ==
+
===Risk Factors===
   
* Previous history of SBP
+
*Previous history of SBP
* Upper GI bleed
+
*[[Upper GI bleed]]
* Low sciatic protein
+
*Low sciatic protein
* Child-Pugh class
+
*Child-Pugh class
   
== Clinical Manifestations ==
+
==Clinical Manifestations==
   
* Asymptomatic in 10%
+
*Asymptomatic in 10%
* Fever (70%)
+
*Fever (70%)
* Abdominal pain (60%)
+
*Abdominal pain (60%)
* Hepatic encephalopathy (50%)
+
*Hepatic encephalopathy (50%)
* Abdominal tenderness, usually without rigidity (50%)
+
*Abdominal tenderness, usually without rigidity (50%)
* Diarrhea (30%)
+
*Diarrhea (30%)
* Ileus (30%)
+
*Ileus (30%)
* Shock (20%)
+
*Shock (20%)
* Hypothermia (15%)
+
*Hypothermia (15%)
   
  +
===Variants===
== Investigations ==
 
   
  +
*'''Culture-negative neutrocytic ascites:''' usually caused by difficult-to-treat organisms like tuberculosis, and non-infective sources
* Labs
 
  +
*'''Monomicrobial non-neutrocytic bacterascites:''' early bacterial colonization
** Ascitic fluid for cell count and culture
 
  +
*'''Polymicrobial bacterascites:''' usually from traumatic paracentesis
*** Neutrophil count < 250 rules it out
 
*** Culture usually monomicrobial
 
** Repeat paracentesis at 48h if ongoing concern
 
* Imaging
 
* Other
 
   
  +
===Prognosis and Complications===
== Management ==
 
   
 
*In-hospital mortality of about 33% in hospital
* Acute
 
 
*58% 6-month mortality
** Ceftriaxone 1-2g IV q24h
 
* Chronic
 
** Prophylaxis after a single episode
 
*** Septra SS PO daily
 
*** Norfloxacin
 
* Some role for primary prophylaxis, I think?
 
   
== Prognosis ==
+
==Investigations==
   
  +
*Diagnostic paracentesis with ascitic fluid sent for cell count with differential and culture
* In-hospital mortality of about 33% in hospital
 
 
**Neutrophil count < 250 rules it out
* 58% 6-month mortality
 
 
**Culture usually monomicrobial
 
*Repeat paracentesis at 48h if ongoing concern
  +
 
==Management==
  +
  +
*[[Is treated by::Ceftriaxone]] 1-2g IV q24h + [[albumin]] 1.5 g/kg on day 1 and 1 g/kg on day 3
  +
  +
==Prevention==
  +
 
*Prophylaxis is indicated after even a single episode of SBP
 
**[[TMP-SMX]] SS or DS PO daily
  +
**[[Norfloxacin]] 400 mg PO daily
  +
**[[Ciprofloxacin]] 500 mg PO daily
  +
**[[Doxycycline]] 100 mg PO daily is under investigations as an alternative[[CiteRef::nguyen2023do]] (see [https://aasld.confex.com/aasld/2020/meetingapp.cgi/Paper/19190 abstract])
 
*Possibly a role for primary prophylaxis
   
 
[[Category:Intra-abdominal infections]]
 
[[Category:Intra-abdominal infections]]

Latest revision as of 14:08, 19 September 2024

Background

  • Primary infection of the ascitic fluid, diagnosed by ascites fluid with positive culture or with neutrophil count greater than 250

Microbiology

Pathophysiology

  • Intestinal bacterial overgrowth with increased intestinal permeability leads to translocation to intestinal lymph notes and bloodstream, which results in hematogenous seeding to ascitic fluid
  • Only occurs in portal hypertension, not in other causes of ascites

Risk Factors

  • Previous history of SBP
  • Upper GI bleed
  • Low sciatic protein
  • Child-Pugh class

Clinical Manifestations

  • Asymptomatic in 10%
  • Fever (70%)
  • Abdominal pain (60%)
  • Hepatic encephalopathy (50%)
  • Abdominal tenderness, usually without rigidity (50%)
  • Diarrhea (30%)
  • Ileus (30%)
  • Shock (20%)
  • Hypothermia (15%)

Variants

  • Culture-negative neutrocytic ascites: usually caused by difficult-to-treat organisms like tuberculosis, and non-infective sources
  • Monomicrobial non-neutrocytic bacterascites: early bacterial colonization
  • Polymicrobial bacterascites: usually from traumatic paracentesis

Prognosis and Complications

  • In-hospital mortality of about 33% in hospital
  • 58% 6-month mortality

Investigations

  • Diagnostic paracentesis with ascitic fluid sent for cell count with differential and culture
    • Neutrophil count < 250 rules it out
    • Culture usually monomicrobial
  • Repeat paracentesis at 48h if ongoing concern

Management

Prevention

  • Prophylaxis is indicated after even a single episode of SBP
  • Possibly a role for primary prophylaxis

References

  1. ^  Ngoc Nguyen, Matthew Crotty, Edward A. Dominguez, Adil Habib, Hector E. Nazario, Zahid M. Vahora, Parvez S. Mantry, Jessiva Rago, Melanie Proffitt, Maisha N. Barnes, Ashwini Mehta, Mangesh R. Pagadala, Jeffrey S. Weinstein. Doxycycline for the prevention of spontaneous bacterial peritonitis. The Liver Meeting. 2023.